- Home
- NMS vs INCR Comparison
NMS vs INCR Comparison
Compare NMS & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMS | INCR |
|---|---|---|
| Founded | 1993 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.0M | 79.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NMS | INCR |
|---|---|---|
| Price | $11.71 | $1.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.0K | ★ 155.3K |
| Earning Date | 01-01-0001 | 02-15-2026 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $72,158,312.00 |
| Revenue This Year | N/A | $69.54 |
| Revenue Next Year | N/A | $41.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.21 | $0.68 |
| 52 Week High | $12.18 | $1.79 |
Technical Indicators
Market Signals| Indicator | NMS | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 36.84 | 33.93 |
| Support Level | $11.64 | $0.68 |
| Resistance Level | $11.89 | $1.51 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 21.79 | 40.68 |
Price Performance
Historical ComparisonAbout NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.